Back to search
FDAFDA · Food and drugs·Recall number D-0769-2021

Erythromycin Topical Solution USP, 2%, 60mL bottle, Rx only, Teligent Pharma, Inc. Buena, NJ 08310, NDC 52565-027-59

Published September 1, 2021 · Recall initiated: July 29, 2021

Summary

FDA records drug Class II recall D-0769-2021, published September 1, 2021 and initiated July 29, 2021. Recalling firm: Teligent Pharma, Inc.; Status: Ongoing; Reported quantity: 7488 bottles; Lot: Lot #: 14892, Exp 1/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective container: possibility for lack of seal integrity.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teligent Pharma, Inc.
Distributor
USA Nationwide
Lot
Lot #: 14892, Exp 1/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Erythromycin Topical Solution USP, 2%, 60mL bottle, Rx only, Teligent Pharma, Inc. Buena, NJ 08310, NDC 52565-027-59 recalled?

Yes. FDA published recall D-0769-2021 on September 1, 2021. Reported hazard: Defective container: possibility for lack of seal integrity.

What should I do if I have this product?

Voluntary: Firm initiated · Letter